Nasolabial Folds
1
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
QT
Q TherapeuticsUT - Salt Lake City
2 programsPerlane and Perlane-LN/A1 trial
Restylane and Restylane-LN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AbbVieNo-Treatment Control
Q TherapeuticsPerlane and Perlane-L
Q TherapeuticsRestylane and Restylane-L
Clinical Trials (3)
Total enrollment: 61 patients across 3 trials
A Study to Assess Adverse Events and Effectiveness of HAC 20L Injections in Adult Participants for the Treatment of Nasolabial Folds
Start: Sep 2023Est. completion: Feb 202561 patients
Phase 2/3Completed
Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose
Start: Jan 2009Est. completion: Apr 2009
N/ACompleted
Safety & Tolerability Study That Compares Restylane to Restylane With Lidocaine While Correcting Wrinkles in the Nasolabial Folds
Start: Nov 2008Est. completion: Mar 2009
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space